MTOR and neoplasm: Subsequently, we isolated tumor proteins and detected the expression of IGF-1 R-PI3K-AKT-mTOR signaling molecules and found that ropivacaine treatment notably reduces the level of IGF-1 R and inactivates the PI3K-AKT-mTOR signaling transduction (Figure 5d-5e, p < 0.01).